TR
EN
Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al.
Öz
Abstract is not required for letter to editor.
Abstract is not required for letter to editor.
Anahtar Kelimeler
Kaynakça
- 1. Erkut M, Ozkaya E, Fidan S, Cosar AM. Fecal Calprotectin at the Time of Diagnosis May Indicate the Presence of Complications in Inflammatory Bowel Disease. J Contemp Med. 2024;14(1):1-8. 2. Flynn S, Eisenstein S. Inflammatory bowel disease presentation and diagnosis. Surg Clin North Am. 2019;99:1051-62. 3. Goldstone RN, Steinhagen RM. Abdominal emergencies in inflammatory bowel disease. Surg Clin North Am.2019;99:1141-50. 4. Ricciuto A, Griffiths AM. Clinical value of fecal calprotectin. Crit Rev Clin Lab Sci. 2019;56:307-20. 5. Sipponen T, Kolho KL. Fecal calprotectin in diagnosis and clinical assessment of inflammatory bowel disease. Scand J Gastroenterol. 2015;50:74-80.
Ayrıntılar
Birincil Dil
İngilizce
Konular
Gastroenteroloji ve Hepatoloji
Bölüm
Editöre Mektup
Yazarlar
Erken Görünüm Tarihi
24 Mayıs 2025
Yayımlanma Tarihi
31 Mayıs 2025
Gönderilme Tarihi
10 Kasım 2024
Kabul Tarihi
28 Nisan 2025
Yayımlandığı Sayı
Yıl 2025 Cilt: 15 Sayı: 3
APA
Başpınar, B., & Güven, İ. E. (2025). Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine, 15(3), 144-145. https://doi.org/10.16899/jcm.1582362
AMA
1.Başpınar B, Güven İE. Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine. 2025;15(3):144-145. doi:10.16899/jcm.1582362
Chicago
Başpınar, Batuhan, ve İbrahim Ethem Güven. 2025. “Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al”. Journal of Contemporary Medicine 15 (3): 144-45. https://doi.org/10.16899/jcm.1582362.
EndNote
Başpınar B, Güven İE (01 Mayıs 2025) Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine 15 3 144–145.
IEEE
[1]B. Başpınar ve İ. E. Güven, “Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al”., Journal of Contemporary Medicine, c. 15, sy 3, ss. 144–145, May. 2025, doi: 10.16899/jcm.1582362.
ISNAD
Başpınar, Batuhan - Güven, İbrahim Ethem. “Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al”. Journal of Contemporary Medicine 15/3 (01 Mayıs 2025): 144-145. https://doi.org/10.16899/jcm.1582362.
JAMA
1.Başpınar B, Güven İE. Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine. 2025;15:144–145.
MLA
Başpınar, Batuhan, ve İbrahim Ethem Güven. “Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al”. Journal of Contemporary Medicine, c. 15, sy 3, Mayıs 2025, ss. 144-5, doi:10.16899/jcm.1582362.
Vancouver
1.Batuhan Başpınar, İbrahim Ethem Güven. Fecal Calprotectin as a Predictor of Complications in IBD: A Commentary on the article by Erkut et al. Journal of Contemporary Medicine. 01 Mayıs 2025;15(3):144-5. doi:10.16899/jcm.1582362